Sort by
Refine Your Search
-
Program
-
Field
-
clinicians to develop cutting-edge technologies that transform healthcare. This position is part of a prestigious Marie Skłodowska-Curie Actions (MSCA) Doctoral Network, offering exceptional training and
-
prestigious Marie Skłodowska-Curie Actions (MSCA) Doctoral Network, offering exceptional training and networking opportunities across leading European research institutions. The MSCA programme supports
-
orientation. King’s offers inclusive benefits to staff, including flexible working, Enhanced Parental Leave, funds for Parents and Carers, and the potential to join community staff networks. About the role
-
variety of diversity and inclusion networks. Staff can apply for flexible working to help them balance the demands of their professional and personal commitments and we offer comprehensive leave policies
-
the context of breast cancer. We foster an inclusive and interdisciplinary culture, providing access to state-of-the-art facilities, training opportunities, and a great network of collaborators. We
-
, consultancy work and contributions to policy development are utilised by a myriad of organisations and networks. By connecting social scientists, biomedical researchers and clinicians, we deliver research-led
-
internationally-recognised expertise, consultancy work and contributions to policy development are utilised by a myriad of organisations and networks. By connecting social scientists, biomedical researchers and
-
working, caring support (including a Parenting and Carers Fund and the Carer’s Career Development Fund), training, and a variety of diversity and inclusion networks. Staff can apply for flexible working
-
contestations over the meaning and purpose of justice in the shift to net zero emissions, which have led to policy gaps, community grievances, and disruptions in global supply chains. At its core is a pioneering
-
, funds for Parents and Carers, and the potential to join community staff networks. About the role The PDRA will conduct research within the Wellcome-funded Speculative Fertilities**: Finance, Pharma, and